5-vial packs save 20% · 15% off single-vial subtotals over $250 · Discounts do not stack
Synova Biotech
Home / Research catalogue / Retatrutide
Synova Biotech Retatrutide 20 mg vial

CANADIAN PEPTIDE RESEARCH SUPPLY

Retatrutide

20 mg

A research-stage triple receptor agonist active at GIP, GLP-1 and glucagon receptors, investigated in studies of receptor activity, energy-balance pathways, glucose regulation and metabolic signalling.

$150.00 CAD

Single vial · $150.00 CAD

5-vial pack · $600.00 CAD · Save 20%

5 vials, each 20 mg. Pack savings cannot be combined with other discounts.

View COA

Research topics

  • GIP receptor activity
  • GLP-1 receptor activity
  • Glucagon receptor activity
  • Metabolic signalling

Related literature

Independent scientific literature supplied for convenient reference.

Retatrutide phase 2 trialRetatrutide trial
Product classification: Supplied for laboratory research and analytical use. Product descriptions summarize research topics and do not constitute medical advice or establish suitability for any particular application.